Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Endocarditis I: Introduction01:25

Endocarditis I: Introduction

651
Introduction:Endocarditis is the infection of the endocardium, the inner lining of the heart and its valves. When the heart muscle is involved, the condition is termed myocarditis, while an infection of the outer lining is called pericarditis. Infective endocarditis (IE) primarily affects the endocardium, where pathogens adhere to the valves or lining, forming vegetation that can lead to severe complications. Infective endocarditis occurs when microorganisms, usually bacteria from other body...
651
Endocarditis III: Medical Management01:18

Endocarditis III: Medical Management

299
Infective endocarditis management involves a multifaceted approach encompassing infection prevention, lifestyle modifications, pharmacological therapy, and surgical management.Infection Prevention:Hand Hygiene: Thorough handwashing is crucial to prevent the spread of infection. Hand hygiene should be performed regularly, especially before and after using the restroom.Oral Hygiene: Good oral hygiene is essential. It includes brushing teeth immediately after waking up and before bed, flossing...
299
Endocarditis II: Clinical Features of Infective Endocarditis01:25

Endocarditis II: Clinical Features of Infective Endocarditis

687
Endocarditis can present various clinical features depending on the causative organism and the patient's underlying health conditions. Initially, the clinical features of infective endocarditis develop gradually, presenting with nonspecific symptoms that can be easily mistaken for other illnesses.General SymptomsEarly symptoms of infective endocarditis are fever, chills, weakness, malaise, fatigue, and weight loss. These symptoms reflect the systemic nature of the infection and the body's...
687
Endocarditis IV: Nursing Management01:29

Endocarditis IV: Nursing Management

513
Infective endocarditis (IE) is a chronic infection of the heart's endocardium, primarily affecting the heart valves. A detailed nursing assessment for a patient with IE involves collecting subjective and objective data to ensure an accurate diagnosis and timely intervention.Subjective DataThe nurse gathers information about the patient's symptoms and complaints during the subjective assessment. Patients with infective endocarditis often report non-specific symptoms that can mimic other...
513
Pulmonary Tuberculosis I01:29

Pulmonary Tuberculosis I

1.1K
Tuberculosis, often called TB, is a contagious illness primarily caused by Mycobacterium tuberculosis. It mainly affects the lung parenchyma but can also impact other body parts.
Causative Organism
The primary infectious agent causing tuberculosis is Mycobacterium tuberculosis, a slow-growing, acid-fast, aerobic rod that exhibits sensitivity to heat and ultraviolet light. Instances of Mycobacterium bovis and Mycobacterium avium contributing to the development of TB infection are rare.
Mode of...
1.1K
Myocarditis III: Medical Management01:14

Myocarditis III: Medical Management

295
Myocarditis: Comprehensive Medical ManagementMyocarditis, the heart muscle inflammation, requires a comprehensive medical management strategy that addresses the underlying cause, provides supportive care, manages symptoms, and reduces cardiac workload.Infections and Autoimmune CausesAdminister appropriate antimicrobial therapy when an infectious agent causes myocarditis. For instance, penicillin treats infections caused by Group A Streptococcus. In cases where autoimmune processes are...
295

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Penicillin Allergy Documentation Completeness in a Large US Healthcare System.

The journal of allergy and clinical immunology. In practice·2026
Same author

"So what's gonna happen when I get out of here?" Qualitative barriers and facilitators to MOUD continuity post-release from jail.

Drug and alcohol dependence·2026
Same author

Exploration of Factors Associated with Clinicians' Opioid Prescribing "Typologies" for Acute Pain.

Journal of prevention (2022)·2026
Same author

Transitions from first drug use to illicit opioid and injection drug use in a multisite rural U.S. cohort of people who use drugs.

Harm reduction journal·2026
Same author

Corrigendum to "Filling in the gaps: A geospatial approach to optimizing placement of methadone clinics in Massachusetts" [Journal of Substance Use and Addiction Treatment, 181 (2026) 209848].

Journal of substance use and addiction treatment·2026
Same author

Cytomegalovirus Viral Load Dynamics and Outcomes After Liver Transplantation in Moderate and Low Risk Patients Treated With Cytomegalovirus Immune Globulin Prophylaxis.

Journal of medical virology·2026

Related Experiment Video

Updated: Mar 12, 2026

Experimental Endocarditis Model of Methicillin Resistant Staphylococcus aureus MRSA in Rat
07:46

Experimental Endocarditis Model of Methicillin Resistant Staphylococcus aureus MRSA in Rat

Published on: June 4, 2012

18.1K

Increasing Infectious Endocarditis Admissions Among Young People Who Inject Drugs.

Alysse G Wurcel1, Jordan E Anderson2, Kenneth K H Chui3

  • 1Department of Geographic Medicine and Infectious Diseases; Department of Public Health and Community Medicine, Tufts University School of Medicine, Boston, Massachusetts.

Open Forum Infectious Diseases
|November 2, 2016
PubMed
Summary
This summary is machine-generated.

Infective endocarditis (IE) hospitalizations linked to injection drug use (IDU-IE) significantly increased from 2000-2013. This rise disproportionately affected younger, white individuals, highlighting a shift in the affected population.

Keywords:
HIVhepatitis C virushospitalizationinfective endocarditispeople who inject drugs

More Related Videos

A Contemporary Warming/Restraining Device for Efficient Tail Vein Injections in a Murine Fungal Sepsis Model
06:02

A Contemporary Warming/Restraining Device for Efficient Tail Vein Injections in a Murine Fungal Sepsis Model

Published on: November 6, 2020

18.3K
High-throughput and Comprehensive Drug Surveillance Using Multisegment Injection-Capillary Electrophoresis-Mass Spectrometry
10:17

High-throughput and Comprehensive Drug Surveillance Using Multisegment Injection-Capillary Electrophoresis-Mass Spectrometry

Published on: April 23, 2019

10.4K

Related Experiment Videos

Last Updated: Mar 12, 2026

Experimental Endocarditis Model of Methicillin Resistant Staphylococcus aureus MRSA in Rat
07:46

Experimental Endocarditis Model of Methicillin Resistant Staphylococcus aureus MRSA in Rat

Published on: June 4, 2012

18.1K
A Contemporary Warming/Restraining Device for Efficient Tail Vein Injections in a Murine Fungal Sepsis Model
06:02

A Contemporary Warming/Restraining Device for Efficient Tail Vein Injections in a Murine Fungal Sepsis Model

Published on: November 6, 2020

18.3K
High-throughput and Comprehensive Drug Surveillance Using Multisegment Injection-Capillary Electrophoresis-Mass Spectrometry
10:17

High-throughput and Comprehensive Drug Surveillance Using Multisegment Injection-Capillary Electrophoresis-Mass Spectrometry

Published on: April 23, 2019

10.4K

Area of Science:

  • Public Health
  • Infectious Diseases
  • Epidemiology

Background:

  • People who inject drugs (PWID) face elevated risks for infective endocarditis (IE).
  • Rising hospitalization rates for prescription opioid and heroin misuse necessitate updated investigations into injection drug use-related IE (IDU-IE).

Purpose of the Study:

  • To investigate trends in hospitalizations for IDU-IE.
  • To analyze demographic shifts in patients hospitalized with IDU-IE.

Main Methods:

  • Utilized the Health Care and Utilization Project National Inpatient Sample (HCUP-NIS) dataset.
  • Analyzed IE hospitalizations between 2000 and 2013, specifically focusing on IDU-IE cases.
  • Examined demographic data including age, race, and gender.

Main Results:

  • The proportion of IE hospitalizations attributed to IDU-IE rose from 7% to 12.1% (2000-2013).
  • Significant increases in IDU-IE hospitalizations were observed among 15- to 34-year-olds (27.1%-42.0%) and white individuals (40.2%-68.9%).
  • While overall female IDU-IE cases were 40.9%, they constituted 53% of cases in the 15- to 34-year-old group.

Conclusions:

  • The demographic profile of patients hospitalized with IDU-IE is shifting towards younger, white, and increasingly female individuals.
  • Urgent need for studies on risk behaviors and targeted harm reduction strategies for young PWID experiencing IDU-IE.
  • Findings underscore the growing public health challenge posed by IDU-IE in a rapidly evolving population.